Aspirina vs Clopidogrel post-ICP: Seguimiento HOST-EXAM (Lancet 2026)

from Inercia Cero: Corazón, Riñón y Metabolismo · host Dr. Gilberto García Bernal

Instagram: ⁠@dr.gilbertogarciabernal⁠Infografías en X: ⁠@GilbertoG_MDAspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial (Lancet, 2026)Este estudio analiza los resultados a 10 años del ensayo HOST-EXAM sobre la monoterapia con clopidogrel comparada con aspirina en pacientes tras una intervención coronaria percutánea. Los autores demuestran que el clopidogrel reduce significativamente el riesgo compuesto de eventos isquémicos y sangrados mayores, manteniendo beneficios acumulativos a lo largo de una década. El artículo sugiere reconsiderar el uso de la aspirina como terapia de primera elección debido a la mayor tolerabilidad y eficacia clínica del clopidogrel en la prevención secundaria crónica.

Episode metadata supplied by the publisher feed · Published May 19, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Aspirina vs Clopidogrel post-ICP: Seguimiento HOST-EXAM (Lancet 2026)

0:00 22:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Inercia Cero: Corazón, Riñón y Metabolismo?

This episode is 22 minutes long.

When was this Inercia Cero: Corazón, Riñón y Metabolismo episode published?

This episode was published on May 19, 2026.

Can I download this Inercia Cero: Corazón, Riñón y Metabolismo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!